Recall Register

Food, drugs, devices › Firms

Gilead Sciences, Inc.

FDA recalling firm · 7 enforcement events · 7 product records · 2013–2024 · CA

Gilead Sciences, Inc. has 7 FDA enforcement events on this register (7 product records) between 2013 and 2024: 7 drug; the busiest year was 2014 with 3.

43% of its events are Class I; the most common class is Class I (3). 0 events are listed as ongoing; the recalling firm's address is in CA.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

InitiatedProduct (first record)TypeClassRecordsStatus
19 Sep 2024Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2DrugClass I1Terminated
3 Dec 2021Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2DrugClass I1Terminated
1 Oct 2014Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.DrugClass II1Terminated
30 Sep 2014Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1DrugClass III1Terminated
19 Feb 2014Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster…DrugClass III1Terminated
20 Jun 2013AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc., San Dimas, CA 91773, NDC 0469-3051-30.DrugClass II1Terminated
31 Jan 2013Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.DrugClass I1Terminated

By type and class

Drug7
Class I3
Class II2
Class III2

Class I: 43% of this firm's events; 18% of all events on the register.

Events by year

13
15
17
19
21
23
25
Enforcement events for Gilead Sciences, Inc. by year initiated.

Questions and answers

How many FDA recalls has Gilead Sciences, Inc. had?

7 enforcement events (7 product records) on this register, 2013–2024: 7 drug.

Are any Gilead Sciences, Inc. recalls ongoing?

0 events are listed as ongoing in the current openFDA export.

What class are Gilead Sciences, Inc. recalls?

3 Class I, 2 Class II, 2 Class III. 43% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.